Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Pranlukast and mirabegron may work as new diabetes drugs.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Rabbit skin with active hair growth shows thicker, redder areas due to larger, more numerous hair follicles and increased blood vessels.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

GLP-1 agonists may increase the risk of hair loss.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Linagliptin slows down premature aging in certain mice.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

Linagliptin may cause hair loss and skin blisters.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.